Brito PC, Hernandez PJC, Fernandez I, Diaz RB, Alfonso SC

Language: Spanish
References: 21
Page: 77-90
PDF size: 391.58 Kb.

ABSTRACT

Introduction: Non alcoholic fatty liver disease (NAFLD) is one of the liver diseases more frequent in the world. It is considered as a risk factor for the development of vascular and oncological diseases. Methods: A prospective and transversal research was carried out between December, 2011and August, 2013 at CIMEQ; it included the study of 102 necropsies to relate vascular and oncological diseases with non alcoholic fatty liver disease. Results: In this study, 11.76% (12 patients) presented liver steatosis. The liver condition was more frequent in men. Conclusion: From the sixth decade of life on and between oncological diseases, hematological diseases were the most frequent of all.

REFERENCES

1. Terán A, Menéndez S, Crespo J. Enfermedad hepática por depósito de grasa. Etiopatogenia, historia natural y tratamiento. Gastroenterol Hepatol. 2011;34(2):1-11.

2. Ludwig J, Viggiano TR, McGill DB, Oha BJ. Nonalcoholic steatohepatitis. En: Clinic experiences with an unnamed disease. Clin Proc. 1980;55(10):434-8.

3. Chalasani N, Younossi Z, Lavine JE, Diehl AM, Brunt EM, Cusi K, et al. The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterol Hepatol. 2012;55(23):2005-23.

4. Falck-Ytter Y, Younossi ZM, Marchesini G, McCullough AJ. Clinical features and natural history of nonalcoholic steatosis syndromes. Semin Liver Dis. 2001;21(8):17-26.

5. Matteoni CA, Younossi ZM, Gramlich T, BoparaiN, Liu YC, McCullough AJ. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterol. 1999;116(32):1413-9.

6. Nalbantoglu I, Brunt EM. Role of liver biopsy in nonalcoholic fatty liver disease. World J Gastroenterol. 2014;20(27):9026-37.

7. Zois CD, Baltayiannis GH, Bekiari A, Goussia A, Karayiannis P, Doukas M, et al. Steatosis and steatohepatitis in postmortem material from Northwestern Greece. World J Gastroenterol. 2010;16(31):3944-9.

8. Mishra S, Yadav D, Gupta M, Mishra H, Sharma P. A study of carotid atherosclerosis in patients with non-alcoholic fatty liver disease. Ind J Clin Biochem. 2013;28(1):79-83.

9. Teran A, Crespo J. Cribado de la enfermedad hepática por depósito de grasa: cómo y a quién. Gastroenterol Hepatol. 2011;34(4):278-88.

10. Lizardi J, Becerra I, Chávez NC, Ramos ME, Uribe M. Prevalencia de hígado graso no alcohólico y síndrome metabólico en población asintomática. Rev Gastroenterol Mex. 2006;71(4):453-9.

11. Hamaguchi M, Kojima T, Takeda N, Nakagawa T, Taniguchi H, Fujii K, et al. The metabolic syndrome as a predictor of nonalcoholic fatty liver disease. Ann Intern Med. 2005;143(45):722-8.

12. Mortalidad. En: Dirección de registros médicos y estadísticas de salud. Anuario Estadístico de Salud 2013. La Habana; 2014. p. 27-83.

13. Morbilidad. En: Dirección de registros médicos y estadísticas de salud. Anuario estadístico de salud 2013. La Habana; 2014. p. 87-114.

14. Bilici A, Ozguroglu M, Mihmanli I, Turna H, Adaletli I. A case-control study of non-alcoholic fatty liver disease in breast cancer. Med Oncol. 2007;24(4):367-71.

15. Bayard M, Holt J, Boroughs E. Nonalcoholic fatty liver disease. Am Fam Physician. 2006;73(11):1961-8.

16. Lu H, Liu H, Hu F, Zou L, Luo S, Sun L. Independent Association between Nonalcoholic Fatty Liver Disease and Cardiovascular Disease: A Systematic Review and Meta-Analysis. Int J Endocrinol. 2013;12(4):9-58.

17. Jiménez A, Gómez L, Díaz G, Carvalí N, Bacardí M. La adiposidad como factor de riesgo del hígado graso no alcohólico. Revisión sistemática. Nutr Hosp. 2014;29(4):771-5.

18. Pérez M, Duarte N, Montero T, Franco S, Winograd R, Brizuela R. Prevalencia del hígado graso no alcohólico en muestras de biopsias hepáticas. Rev Cub Med Mil. 2006;35(4):23.

19. Montero T, Pérez M, Alarcón I, Infante M, Angulo O, Winogra R, et al. Prevalencia de esteatosis hepática no alcohólica en autopsias y alteraciones morfológicas metabólicas relacionadas. Rev Cub Med Mil. 2011;40(1):32-9.

20. Muhidin SO, Magan AA, Osman KA, Ahmed MH. The relationship between Nonalcoholic Fatty Liver Disease and Colorectal Cancer: The Future Challenges and Outcomes of the Metabolic Syndrome. J Obes. 2012;63(7):5-38.

21. Wong VW, Wong GL, Tsang SW, Fan T, Chu WC, Woo J, et al. High prevalence of colorectal neoplasm in patients with non-alcoholic steatohepatitis. Gut. 2011;60(6):829-36.